DYAI
Price
$1.23
Change
-$0.01 (-0.81%)
Updated
Apr 17 closing price
Capitalization
37.01M
19 days until earnings call
NAUT
Price
$0.76
Change
+$0.04 (+5.56%)
Updated
Apr 17 closing price
Capitalization
95.62M
17 days until earnings call
Ad is loading...

DYAI vs NAUT

Header iconDYAI vs NAUT Comparison
Open Charts DYAI vs NAUTBanner chart's image
Dyadic International
Price$1.23
Change-$0.01 (-0.81%)
Volume$14.07K
Capitalization37.01M
Nautilus Biotechnolgy
Price$0.76
Change+$0.04 (+5.56%)
Volume$88.11K
Capitalization95.62M
DYAI vs NAUT Comparison Chart
Loading...
DYAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYAI vs. NAUT commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYAI is a Hold and NAUT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (DYAI: $1.23 vs. NAUT: $0.76)
Brand notoriety: DYAI and NAUT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYAI: 33% vs. NAUT: 58%
Market capitalization -- DYAI: $37.01M vs. NAUT: $95.62M
DYAI [@Biotechnology] is valued at $37.01M. NAUT’s [@Biotechnology] market capitalization is $95.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYAI’s FA Score shows that 0 FA rating(s) are green whileNAUT’s FA Score has 1 green FA rating(s).

  • DYAI’s FA Score: 0 green, 5 red.
  • NAUT’s FA Score: 1 green, 4 red.
According to our system of comparison, NAUT is a better buy in the long-term than DYAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYAI’s TA Score shows that 4 TA indicator(s) are bullish while NAUT’s TA Score has 5 bullish TA indicator(s).

  • DYAI’s TA Score: 4 bullish, 4 bearish.
  • NAUT’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, NAUT is a better buy in the short-term than DYAI.

Price Growth

DYAI (@Biotechnology) experienced а +2.50% price change this week, while NAUT (@Biotechnology) price change was +2.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

DYAI is expected to report earnings on May 08, 2025.

NAUT is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAUT($95.6M) has a higher market cap than DYAI($37M). DYAI YTD gains are higher at: -29.714 vs. NAUT (-54.881). DYAI has higher annual earnings (EBITDA): -7.42M vs. NAUT (-75.12M). NAUT has more cash in the bank: 130M vs. DYAI (9.92M). DYAI has less debt than NAUT: DYAI (5.37M) vs NAUT (30.5M). DYAI has higher revenues than NAUT: DYAI (3.37M) vs NAUT (0).
DYAINAUTDYAI / NAUT
Capitalization37M95.6M39%
EBITDA-7.42M-75.12M10%
Gain YTD-29.714-54.88154%
P/E RatioN/AN/A-
Revenue3.37M0-
Total Cash9.92M130M8%
Total Debt5.37M30.5M18%
FUNDAMENTALS RATINGS
DYAI vs NAUT: Fundamental Ratings
DYAI
NAUT
OUTLOOK RATING
1..100
9157
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9895
PRICE GROWTH RATING
1..100
6296
P/E GROWTH RATING
1..100
61100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NAUT's Valuation (14) in the null industry is significantly better than the same rating for DYAI (94) in the Biotechnology industry. This means that NAUT’s stock grew significantly faster than DYAI’s over the last 12 months.

NAUT's Profit vs Risk Rating (100) in the null industry is in the same range as DYAI (100) in the Biotechnology industry. This means that NAUT’s stock grew similarly to DYAI’s over the last 12 months.

NAUT's SMR Rating (95) in the null industry is in the same range as DYAI (98) in the Biotechnology industry. This means that NAUT’s stock grew similarly to DYAI’s over the last 12 months.

DYAI's Price Growth Rating (62) in the Biotechnology industry is somewhat better than the same rating for NAUT (96) in the null industry. This means that DYAI’s stock grew somewhat faster than NAUT’s over the last 12 months.

DYAI's P/E Growth Rating (61) in the Biotechnology industry is somewhat better than the same rating for NAUT (100) in the null industry. This means that DYAI’s stock grew somewhat faster than NAUT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DYAINAUT
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
DYAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla
BTC.X84450.805000-444.945300
-0.52%
Bitcoin cryptocurrency

DYAI and

Correlation & Price change

A.I.dvisor tells us that DYAI and FBRX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DYAI and FBRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYAI
1D Price
Change %
DYAI100%
-0.81%
FBRX - DYAI
28%
Poorly correlated
+1.10%
CGTX - DYAI
27%
Poorly correlated
-0.21%
APLS - DYAI
26%
Poorly correlated
+0.22%
VYNE - DYAI
24%
Poorly correlated
+1.65%
NAUT - DYAI
23%
Poorly correlated
+4.80%
More

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with FHTX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
+4.80%
FHTX - NAUT
52%
Loosely correlated
+9.51%
KYMR - NAUT
52%
Loosely correlated
+3.80%
ABOS - NAUT
46%
Loosely correlated
-8.08%
NRIX - NAUT
45%
Loosely correlated
+4.49%
IMNM - NAUT
45%
Loosely correlated
+10.32%
More